Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Diagnosis and Treatment of Rare Gynecologic Cancers
- 1st Edition - May 10, 2022
- Authors: Michael Frumovitz, Mario M. Leitao Jr., Preetha Ramalingam
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 8 2 9 3 8 - 0
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 2 9 3 9 - 7
Offering a one-stop guide to recognition and therapeutic decision making, Diagnosis and Treatment of Rare Gynecologic Cancers fills a gap in the medical literature on uncommon ov… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteOffering a one-stop guide to recognition and therapeutic decision making, Diagnosis and Treatment of Rare Gynecologic Cancers fills a gap in the medical literature on uncommon ovarian, uterine, cervical, and vulvovaginal cancers and trophoblastic diseases. This authoritative text, edited by Drs. Michael Frumovitz, Mario Leitao, and Preetha Ramalingam, has been authored by internationally recognized experts from top institutions such as MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Each chapter covers different cancer subtypes and has been reviewed by an oncologist and a pathologist.
-
Provides up-to-date clinical guidance on assessment and therapeutic options for patients with rare gynecologic malignancies.
-
Presents information in a templated, easy-to-read format. Each chapter includes an introductory clinical case followed by epidemiology of disease, pathologic assessment, basic science/molecular/translational research, work-up of newly diagnosed disease, staging, treatment of newly diagnosed disease, treatment of recurrent disease, potential therapeutic targets, and a case resolution.
-
Includes diagnostic and treatment algorithms for each form of cancer.
-
Contains numerous anatomical figures, radiographs, photographs, and tables for quick visual reference.
-
Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
Gynecologists, oncologists
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- Contributors
- Foreword
- Section A: Ovarian cancers
- Introduction
- Chapter 1: Malignant ovarian germ cell tumors
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging
- Management
- Surveillance
- Chemotherapy
- Posttreatment surveillance
- Recurrent disease
- Growing teratoma syndrome
- Case follow-up
- References
- Chapter 2: Sex cord stromal tumors of the ovary
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging system
- Prognostic factors
- Treatment of primary disease
- Surveillance for recurrence
- Survival and patterns of failure
- Treatment of recurrent disease
- Special considerations
- Case resolution
- References
- Chapter 3: Ovarian carcinosarcoma
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging system
- Prognostic factors
- Treatment of primary disease
- Surveillance for recurrent disease
- Survival and patterns of failure
- Treatment of recurrent disease
- Targeted therapy
- Case resolution
- References
- Chapter 4: Ovarian clear cell carcinoma
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging system
- Prognostic factors
- Treatment of primary disease
- Systemic treatment of ovarian clear cell carcinoma
- Surveillance for recurrence
- Survival and patterns of failure
- Treatment of recurrent disease
- Case resolution
- References
- Chapter 5: Mucinous ovarian carcinomas
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Prognostic factors
- Treatment of primary disease
- Surveillance for recurrent disease
- Survival and patterns of failure
- Treatment of recurrent disease
- Special considerations
- Case resolution
- References
- Chapter 6: Low-grade serous ovarian cancer
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging system
- Prognostic factors
- Treatment of primary disease
- Surveillance for recurrence
- Survival and patterns of failure
- Treatment of recurrent disease
- Case resolution
- References
- Chapter 7: Small cell carcinoma of the ovary, hypercalcemic type
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging system
- Prognostic factors
- Treatment of primary disease
- Treatment of recurrent disease
- Case resolution
- References
- Chapter 8: Other rare ovarian cancers: Transitional cell carcinoma, malignant Brenner tumor, endometrioid carcinoma, mesothelioma, squamous cell carcinoma, sarcoma
- Abstract
- Introduction
- Transitional cell carcinoma
- Malignant Brenner tumors
- Endometrioid carcinoma
- Neuroendocrine tumors
- Mesothelioma
- Squamous cell carcinoma
- Sarcoma
- References
- Section B: Uterine cancers
- Introduction
- Chapter 9: Uterine leiomyosarcoma
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging system
- Prognostic factors
- Treatment of primary disease
- Adjuvant therapy in early-stage disease
- Surveillance for recurrence
- Survival and patterns of failure
- Treatment of advanced or recurrent disease
- Case resolution
- References
- Chapter 10: Other rare uterine sarcomas: Adenosarcoma, endometrial stromal sarcoma, STUMP
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging
- Prognostic factors
- Treatment of primary disease
- Surveillance for recurrence
- Survival and patterns of failure
- Treatment of recurrent disease
- Clinical case resolution
- References
- Chapter 11: Uterine carcinosarcoma
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging system
- Prognostic factors
- Treatment of primary disease
- Surveillance
- Recurrent disease
- Case resolution
- References
- Chapter 12: Uterine serous carcinoma
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging system
- Prognostic factors
- Treatment of primary disease
- Surveillance for recurrence
- Survival and patterns of failure
- Treatment of recurrent disease
- Case resolution
- References
- Chapter 13: Other rare uterine cancers: neuroendocrine tumors, yolk sac tumors, choriocarcinoma
- Abstract
- Neuroendocrine tumors
- Yolk sac tumors
- Choriocarcinoma
- References
- Section C: Cervical cancers
- Introduction
- Chapter 14: High grade neuroendocrine carcinoma of the cervix
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging system
- Prognostic factors
- Treatment of primary disease
- Surveillance for recurrent disease
- Survival and patterns of failure
- Treatment of recurrent disease
- Special considerations
- Case resolution
- References
- Chapter 15: Other rare cervical cancers: cervical rhabdomyosarcoma, adenoid cystic carcinoma, verrucous carcinoma
- Abstract
- Introduction
- Cervical rhabdomyoscarcoma
- Adenoid cystic carcinoma
- Verrucous carcinoma
- References
- Chapter 16: Clear cell carcinoma of the vagina and cervix
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging system
- Prognostic factors
- Treatment of primary disease
- Surveillance for recurrent disease
- Survival and patterns of failure
- Treatment of recurrent disease
- Special considerations
- Case resolution
- References
- Section D: Vulvovaginal cancers
- Introduction
- Chapter 17: Vulvovaginal melanoma
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging system
- Prognostic factors
- Treatment of primary disease
- Surveillance for recurrence
- Treatment of recurrent disease
- Special considerations
- Case resolution
- References
- Chapter 18: Bartholin gland carcinomas
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and work-up
- Staging system
- Prognostic factors
- Treatment of primary disease
- Survival and patterns of failure
- Case resolution
- References
- Chapter 19: Vulvar extramammary Paget disease
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and work-up
- Staging system
- Prognostic factors
- Treatment of primary disease
- Surveillance for recurrent disease
- Survival and patterns of failure
- Treatment of recurrent disease
- Special considerations
- Case resolution
- References
- Chapter 20: Other rare vulvovaginal cancers: Verrucous carcinoma, aggressive angiomyxoma, vulvar yolk sac tumor
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and work-up
- Staging
- Treatment of primary disease
- Surveillance for recurrence
- Survival and patterns of failure
- Case resolution
- References
- Section E: Gestational trophoblastic disease
- Introduction
- Chapter 21: Gestational trophoblastic disease
- Abstract
- Clinical case
- Epidemiology
- Pathology
- Diagnosis and workup
- Staging system
- Prognostic factors
- Treatment of primary disease
- Surveillance for recurrent disease
- Survival and patterns of failure
- Treatment of recurrent disease
- Special considerations
- Case resolution
- References
- Index
- No. of pages: 384
- Language: English
- Edition: 1
- Published: May 10, 2022
- Imprint: Elsevier
- Hardback ISBN: 9780323829380
- eBook ISBN: 9780323829397
MF
Michael Frumovitz
Affiliations and expertise
Professor, Gynecologic Oncology, MD Anderson Cancer CenterML
Mario M. Leitao Jr.
Affiliations and expertise
Member and Fellowship Director, Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medical College.PR
Preetha Ramalingam
MD
Affiliations and expertise
Professor, Anatomic Pathology, MD Anderson Cancer Center